BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16019947)

  • 1. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis.
    Ansede JH; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE
    Xenobiotica; 2005 Mar; 35(3):211-26. PubMed ID: 16019947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.
    Ju W; Yang S; Ansede JH; Stephens CE; Bridges AS; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE; Wang MZ
    J Pharm Sci; 2014 Jan; 103(1):337-49. PubMed ID: 24186380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.
    Thuita JK; Wang MZ; Kagira JM; Denton CL; Paine MF; Mdachi RE; Murilla GA; Ching S; Boykin DW; Tidwell RR; Hall JE; Brun R
    PLoS Negl Trop Dis; 2012; 6(7):e1734. PubMed ID: 22848769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes.
    Mathis AM; Holman JL; Sturk LM; Ismail MA; Boykin DW; Tidwell RR; Hall JE
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2185-91. PubMed ID: 16723581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.
    Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection.
    Ansede JH; Anbazhagan M; Brun R; Easterbrook JD; Hall JE; Boykin DW
    J Med Chem; 2004 Aug; 47(17):4335-8. PubMed ID: 15294005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry.
    Zhou L; Thakker DR; Voyksner RD; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
    J Mass Spectrom; 2004 Apr; 39(4):351-60. PubMed ID: 15103648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
    Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
    Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue.
    Sturk LM; Brock JL; Bagnell CR; Hall JE; Tidwell RR
    Acta Trop; 2004 Jul; 91(2):131-43. PubMed ID: 15234662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.
    Yang S; Wenzler T; Miller PN; Wu H; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4064-74. PubMed ID: 24798280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes.
    Mathis AM; Bridges AS; Ismail MA; Kumar A; Francesconi I; Anbazhagan M; Hu Q; Tanious FA; Wenzler T; Saulter J; Wilson WD; Brun R; Boykin DW; Tidwell RR; Hall JE
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2801-10. PubMed ID: 17517831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DB-289 Immtech International.
    Yeates C
    IDrugs; 2003 Nov; 6(11):1086-93. PubMed ID: 14600842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models.
    Yan GZ; Brouwer KL; Pollack GM; Wang MZ; Tidwell RR; Hall JE; Paine MF
    J Pharmacol Exp Ther; 2011 May; 337(2):503-12. PubMed ID: 21320872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.
    Zhou L; Voyksner RD; Thakker DR; Stephens CE; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
    Rapid Commun Mass Spectrom; 2002; 16(11):1078-85. PubMed ID: 11992511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
    Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
    Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis.
    Thuita JK; Karanja SM; Wenzler T; Mdachi RE; Ngotho JM; Kagira JM; Tidwell R; Brun R
    Acta Trop; 2008 Oct; 108(1):6-10. PubMed ID: 18722336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of metabolites of a NK1 receptor antagonist, CJ-11,972, in human liver microsomes and recombinant human CYP isoforms by liquid chromatography/tandem mass spectrometry.
    Prakash C; Lin J; Colizza K; Miao Z
    Rapid Commun Mass Spectrom; 2007; 21(17):2822-32. PubMed ID: 17661339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Metabolic Soft-Spot Identification in Liver Microsomes by LC/UV/MS: Application of a Single Variable Incubation Time Approach.
    Zhu Y; Chen G; Zhang K; Chen C; Chen W; Zhu M; Jiang H
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.